Company Filing History:
Years Active: 2021
Title: John Jacob Requard, III: Innovator in Therapeutic Delivery Systems
Introduction
John Jacob Requard, III is a notable inventor based in Apex, North Carolina. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of age-related macular degeneration (AMD) and other eye diseases. His innovative approach focuses on the use of cell-penetrating peptides to enhance the delivery of therapeutic agents.
Latest Patents
Requard holds a patent for "Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseases." This patent outlines a method for delivering therapeutic agents that can treat various stages and phenotypes of AMD. The therapeutic agents may include anti-dyslipidemic agents, antioxidants, anti-inflammatory agents, complement inhibitors, neuroprotectors, and anti-angiogenic agents. The invention emphasizes the use of cell-penetrating peptides to improve the efficacy of these agents, which can be administered through eye drops.
Career Highlights
Requard is associated with Macregen, Inc., where he continues to develop innovative solutions for eye health. His work is pivotal in advancing therapeutic options for patients suffering from AMD and related conditions. With a focus on practical applications, he aims to improve patient outcomes through his inventions.
Collaborations
Requard collaborates with Keith Roizman, a fellow innovator in the field. Their partnership enhances the research and development efforts at Macregen, Inc., contributing to the advancement of therapeutic technologies.
Conclusion
John Jacob Requard, III is a prominent figure in the field of therapeutic delivery systems, with a focus on improving treatments for age-related macular degeneration. His innovative patent and ongoing work at Macregen, Inc. highlight his commitment to advancing eye health solutions.